Open Nav

Steven Braithwaite, PhD

Chief Scientific Officer

Alkahest

Steven has extensive experience in therapeutic development in the biotechnology and pharmaceutical industries. He previously led research at Circuit Therapeutics, drug discovery at Signum Biosciences, headed the cellular neurodegeneration group at Wyeth/Pfizer, and was a program leader at AGY Therapeutics. In these roles he has led both small molecule and biological research and development programs across a diverse range of indications in the field of neuroscience. Steven is a graduate of the University of Cambridge, UK, received his PhD from the University of Bristol, UK and performed postdoctoral work at Stanford University. He is actively involved with the Michael J Fox Foundation for Parkinson’s Disease Research and the Alzheimer’s Drug Discovery Foundation.

This speaker's sessions:

Back